Comparison of the tumor mutation burden (TMB) analysis results between a targeted next-generation sequencing method and the conventional WES method. This is an ASCO Meeting Abstract from the 2018 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results